ISRG
INTUITIVE SURGICAL INC
Orthopedic, Prosthetic & Surgical Appliances & SuppliesNasdaqLarge accelerated filer
Total Trades
231
Buys
0
Sells
126
Largest Trade
N/A
Insiders
18
Institutional Funds
2,167
Inst. Value
$1M+
Activist Filings
6
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Brosius Mark | SVP & Chief Mfg an… | SELL | $1M+ | 2K | $514.95 | Oct 24, 2024 |
| Brosius Mark | SVP & Chief Mfg an… | EXERCISE | $100K–$500K | 2K | $77.00 | Oct 24, 2024 |
| Miller Brian Edward | EVP & Chief Digita… | SELL | $1M+ | 3K | $515.00 | Oct 23, 2024 |
| DeSantis Robert | EVP & Chief Strate… | EXERCISE | $50K–$100K | 376 | $249.62 | Aug 29, 2024 |
| DeSantis Robert | EVP & Chief Strate… | SELL | $100K–$500K | 376 | $482.57 | Aug 29, 2024 |
| DeSantis Robert | EVP & Chief Strate… | SELL | $100K–$500K | 396 | $486.88 | Aug 26, 2024 |
| DeSantis Robert | EVP & Chief Strate… | EXERCISE | $100K–$500K | 396 | $296.51 | Aug 26, 2024 |
| Charlton Henry L | SVP & Chief Commer… | SELL | $1M+ | 40K | $486.84 | Aug 26, 2024 |
| Charlton Henry L | SVP & Chief Commer… | EXERCISE | $1M+ | 20K | $142.20 | Aug 26, 2024 |
| GUTHART GARY S | CEO | SELL | $1M+ | 31K | $443.56 | Jul 31, 2024 |
| GUTHART GARY S | CEO | EXERCISE | $1M+ | 25K | $57.11 | Jul 31, 2024 |
| BARRATT CRAIG H | Director | SELL | $500K+ | 1K | $421.06 | Jun 13, 2024 |
| BARRATT CRAIG H | Director | EXERCISE | $50K–$100K | 1K | $56.97 | Jun 13, 2024 |
| DeSantis Robert | EVP & Chief Strate… | SELL | $50K–$100K | 239 | $416.60 | Jun 11, 2024 |
| DeSantis Robert | EVP & Chief Strate… | EXERCISE | $50K–$100K | 239 | $266.87 | Jun 11, 2024 |
| BARRATT CRAIG H | Director | SELL | $500K+ | 1K | $411.00 | Jun 6, 2024 |
| BARRATT CRAIG H | Director | EXERCISE | $50K–$100K | 1K | $56.97 | Jun 6, 2024 |
| BARRATT CRAIG H | Director | SELL | $1M+ | 2K | $402.89 | Jun 4, 2024 |
| BARRATT CRAIG H | Director | EXERCISE | $100K–$500K | 2K | $56.97 | Jun 4, 2024 |
| DeSantis Robert | EVP & Chief Strate… | EXERCISE | $100K–$500K | 772 | $273.67 | May 30, 2024 |
| DeSantis Robert | EVP & Chief Strate… | SELL | $100K–$500K | 772 | $402.51 | May 30, 2024 |
| DeSantis Robert | EVP & Chief Strate… | EXERCISE | $500K+ | 2K | $268.31 | Apr 30, 2024 |
| DeSantis Robert | EVP & Chief Strate… | SELL | $500K+ | 2K | $371.02 | Apr 30, 2024 |
| LEVY ALAN J | Director | SELL | $500K+ | 2K | $370.70 | Apr 24, 2024 |
| LEVY ALAN J | Director | EXERCISE | $100K–$500K | 2K | $154.24 | Apr 24, 2024 |
| Curet Myriam | EVP & Chief Medica… | EXERCISE | $500K+ | 5K | $180.27 | Apr 24, 2024 |
| Curet Myriam | EVP & Chief Medica… | SELL | $1M+ | 5K | $370.66 | Apr 24, 2024 |
| Curet Myriam | EVP & Chief Medica… | SELL | $500K+ | 2K | $383.48 | Mar 1, 2024 |
| MOHR MARSHALL | Executive VP Globa… | EXERCISE | $1M+ | 133K | $138.87 | Mar 1, 2024 |
| MOHR MARSHALL | Executive VP Globa… | SELL | $1M+ | 109K | $385.08 | Mar 1, 2024 |
| Curet Myriam | EVP & Chief Medica… | SELL | $100K–$500K | 843 | $386.46 | Feb 27, 2024 |
| Curet Myriam | EVP & Chief Medica… | EXERCISE | N/A | 2K | — | Feb 27, 2024 |
| Brosius Mark | SVP & Chief Mfg an… | SELL | $15K–$50K | 92 | $380.10 | Feb 16, 2024 |
| Brosius Mark | SVP & Chief Mfg an… | SELL | $15K–$50K | 60 | $380.80 | Feb 13, 2024 |
| Curet Myriam | EVP & Chief Medica… | EXERCISE | N/A | 838 | — | Feb 13, 2024 |
| Curet Myriam | EVP & Chief Medica… | SELL | $100K–$500K | 481 | $386.09 | Feb 13, 2024 |
| Rosa David J. | President | EXERCISE | $1M+ | 141K | $52.37 | Feb 8, 2024 |
| Rosa David J. | President | SELL | $1M+ | 81K | $389.28 | Feb 8, 2024 |
| Brosius Mark | SVP & Chief Mfg an… | SELL | $1K–$15K | 39 | $378.41 | Feb 5, 2024 |
| GUTHART GARY S | CEO | EXERCISE | $1M+ | 34K | $51.02 | Jan 30, 2024 |
| GUTHART GARY S | CEO | SELL | $1M+ | 29K | $375.78 | Jan 30, 2024 |
| Curet Myriam | EVP & Chief Medica… | SELL | $1M+ | 4K | $370.15 | Jan 29, 2024 |
| Curet Myriam | EVP & Chief Medica… | EXERCISE | $500K+ | 4K | $179.67 | Jan 29, 2024 |
| LEVY ALAN J | Director | SELL | $500K+ | 2K | $370.20 | Jan 29, 2024 |
| LEVY ALAN J | Director | EXERCISE | $100K–$500K | 2K | $92.79 | Jan 29, 2024 |
| Johnson Amal M | Director | EXERCISE | $100K–$500K | 7K | $56.97 | Jan 29, 2024 |
| Johnson Amal M | Director | SELL | $1M+ | 7K | $370.08 | Jan 29, 2024 |
| Johnson Amal M | Director | SELL | $1M+ | 10K | $300.00 | Nov 17, 2023 |
| Johnson Amal M | Director | EXERCISE | $100K–$500K | 10K | $41.26 | Nov 17, 2023 |
| Curet Myriam | EVP & Chief Medica… | SELL | $1M+ | 9K | $300.00 | Nov 17, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 2,167 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 15.7M | $1M+ | SH |
| Capital World Investors | 7.9M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 7.2M | $1M+ | SH |
| NORGES BANK | 5.0M | $1M+ | SH |
| Fisher Asset Management, LLC | 3.8M | $1M+ | SH |
| J. Stern & Co. LLP | 2.1M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 3.7M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 3.1M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.6M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 2.1M | $1M+ | SH |
| EDGEWOOD MANAGEMENT LLC | 1.8M | $1M+ | SH |
| Clearbridge Investments, LLC | 1.7M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.5M | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 1.5M | $1M+ | SH |
| VICTORY CAPITAL MANAGEMENT INC | 1.5M | $1M+ | SH |
| BARCLAYS PLC | 1.5M | $1M+ | SH |
| Sumitomo Mitsui Trust Group, Inc. | 1.4M | $1M+ | SH |
| SANDS CAPITAL MANAGEMENT, LLC | 1.4M | $1M+ | SH |
| Capital Research Global Investors | 1.2M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.2M | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
4.8%
17.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.6%
30.4M shares
SC 13G/A · Jan 25, 2024
8.4%
29.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
5.9%
20.8M shares
SC 13G/A · Feb 3, 2023
8.0%
28.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
6.9%
24.8M shares